HDA

The Obstacles That Impede Biosimilars
The Obstacles That Impede BiosimilarsHurdles to adoption of biosimilars include regulatory issues and lack of interchangeability with the reference drugs.
Specialty Pharmacy Will Gain a Bigger Chunk of U.S. PharmaceuticalsThe specialty explosion is only going to get bigger.
Pharmacy Community Reacts to 60 Minutes/Washington Post Investigation
Pharmacy Community Reacts to 60 Minutes/Washington Post InvestigationThe investigation is causing far-reaching ripples around the country, but how does it affect pharmacists?